Daniel O'Day Sells Shares in Gilead Sciences

Daniel P. O'Day, Chairman & CEO of Gilead Sciences, Inc., sold a total of 10,000 shares of common stock on October 28, 2025. The transactions were executed at prices ranging from $118.61 to $120.06 per share, resulting in total proceeds of approximately $1.19 million. These sales were made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. Following the transactions, O'Day's ownership in Gilead Sciences decreased to 581,203 shares. The sales were reported in a Form 4 filing with the SEC.